Effect of corosolic acid on gluconeogenesis in rat liver

Abstract Corosolic acid (CRA), an active component of Banaba leaves ( Lagerstroemia speciosa L.), decreases blood glucose in diabetic animals and humans. In this study, we investigated the mechanism of action of CRA on gluconeogenesis in rat liver. CRA (20–100 μM) dose-dependently decreased gluconeo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes research and clinical practice 2008-04, Vol.80 (1), p.48-55
Hauptverfasser: Yamada, Kotaro, Hosokawa, Masaya, Fujimoto, Shimpei, Fujiwara, Hideya, Fujita, Yoshihito, Harada, Norio, Yamada, Chizumi, Fukushima, Mitsuo, Ueda, Naoya, Kaneko, Tetsuo, Matsuyama, Futoshi, Yamada, Yuichiro, Seino, Yutaka, Inagaki, Nobuya
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 55
container_issue 1
container_start_page 48
container_title Diabetes research and clinical practice
container_volume 80
creator Yamada, Kotaro
Hosokawa, Masaya
Fujimoto, Shimpei
Fujiwara, Hideya
Fujita, Yoshihito
Harada, Norio
Yamada, Chizumi
Fukushima, Mitsuo
Ueda, Naoya
Kaneko, Tetsuo
Matsuyama, Futoshi
Yamada, Yuichiro
Seino, Yutaka
Inagaki, Nobuya
description Abstract Corosolic acid (CRA), an active component of Banaba leaves ( Lagerstroemia speciosa L.), decreases blood glucose in diabetic animals and humans. In this study, we investigated the mechanism of action of CRA on gluconeogenesis in rat liver. CRA (20–100 μM) dose-dependently decreased gluconeogenesis in perfused liver and in isolated hepatocytes. Fructose-2,6-bisphosphate (F-2,6-BP), a gluconeogenic intermediate, plays a critical role in hepatic glucose output by regulating gluconeogenesis and glycolysis in the liver. CRA increased the production of F-2,6-BP along with a decrease in intracellular levels of cAMP both in the presence and in the absence of forskolin in isolated hepatocytes. While a cAMP-dependent protein kinase (PKA) inhibitor inhibited hepatic gluconeogenesis, the drug did not intensify the inhibitory effect of CRA on hepatic gluconeogenesis in isolated hepatocytes. These results indicate that CRA inhibits gluconeogenesis by increasing the production of F-2,6-BP by lowering the cAMP level and inhibiting PKA activity in isolated hepatocytes. Furthermore, CRA increased glucokinase activity in isolated hepatocytes without affecting glucose-6-phosphatase activity, suggesting the promotion of glycolysis. These effects on hepatic glucose metabolism may underlie the various anti-diabetic actions of CRA.
doi_str_mv 10.1016/j.diabres.2007.11.011
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70434208</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0168822707006055</els_id><sourcerecordid>70434208</sourcerecordid><originalsourceid>FETCH-LOGICAL-c484t-f49d0f440de65979afc119db5ac803459f524dc1f61ce96c0c308913dfba5da23</originalsourceid><addsrcrecordid>eNqFkU1P3DAQhq2qVdnS_oSinLhtOpM4sXMBIQS0ElIP0LPlHY-Rt9kY7A0S_x5vdyUkLj3Zh2e-nleI7wg1AvY_1rULdpU41w2AqhFrQPwgFqhVs9RNoz6KReH0v_-R-JLzGgD6VnafxRFqVGpQ7ULoK--ZtlX0FcUUcxwDVZaCq-JUPYwzxYnjA0-cQ67CVCW7rcbwzOmr-OTtmPnb4T0Wf66v7i9_Lm9_3_y6vLhdktRyu_RycOClBMd9N6jBekIc3KqzpKEsM_iukY7Q90g89ATUgh6wdX5lO2eb9lic7vs-pvg0c96aTcjE42jLYnM2CmQrG9AF7PYglTNyYm8eU9jY9GIQzE6ZWZuDMrNTZhBNUVbqTg4D5tWG3VvVwVEBzvcAlzOfAyeTKfBE7EIq6oyL4b8jzt51oDFMgez4l184r-OcpuLQoMmNAXO3y20XG6iSGHRd-wrRGpPE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70434208</pqid></control><display><type>article</type><title>Effect of corosolic acid on gluconeogenesis in rat liver</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Yamada, Kotaro ; Hosokawa, Masaya ; Fujimoto, Shimpei ; Fujiwara, Hideya ; Fujita, Yoshihito ; Harada, Norio ; Yamada, Chizumi ; Fukushima, Mitsuo ; Ueda, Naoya ; Kaneko, Tetsuo ; Matsuyama, Futoshi ; Yamada, Yuichiro ; Seino, Yutaka ; Inagaki, Nobuya</creator><creatorcontrib>Yamada, Kotaro ; Hosokawa, Masaya ; Fujimoto, Shimpei ; Fujiwara, Hideya ; Fujita, Yoshihito ; Harada, Norio ; Yamada, Chizumi ; Fukushima, Mitsuo ; Ueda, Naoya ; Kaneko, Tetsuo ; Matsuyama, Futoshi ; Yamada, Yuichiro ; Seino, Yutaka ; Inagaki, Nobuya</creatorcontrib><description>Abstract Corosolic acid (CRA), an active component of Banaba leaves ( Lagerstroemia speciosa L.), decreases blood glucose in diabetic animals and humans. In this study, we investigated the mechanism of action of CRA on gluconeogenesis in rat liver. CRA (20–100 μM) dose-dependently decreased gluconeogenesis in perfused liver and in isolated hepatocytes. Fructose-2,6-bisphosphate (F-2,6-BP), a gluconeogenic intermediate, plays a critical role in hepatic glucose output by regulating gluconeogenesis and glycolysis in the liver. CRA increased the production of F-2,6-BP along with a decrease in intracellular levels of cAMP both in the presence and in the absence of forskolin in isolated hepatocytes. While a cAMP-dependent protein kinase (PKA) inhibitor inhibited hepatic gluconeogenesis, the drug did not intensify the inhibitory effect of CRA on hepatic gluconeogenesis in isolated hepatocytes. These results indicate that CRA inhibits gluconeogenesis by increasing the production of F-2,6-BP by lowering the cAMP level and inhibiting PKA activity in isolated hepatocytes. Furthermore, CRA increased glucokinase activity in isolated hepatocytes without affecting glucose-6-phosphatase activity, suggesting the promotion of glycolysis. These effects on hepatic glucose metabolism may underlie the various anti-diabetic actions of CRA.</description><identifier>ISSN: 0168-8227</identifier><identifier>EISSN: 1872-8227</identifier><identifier>DOI: 10.1016/j.diabres.2007.11.011</identifier><identifier>PMID: 18177973</identifier><language>eng</language><publisher>Ireland: Elsevier Ireland Ltd</publisher><subject>Animals ; cAMP ; Carbon Radioisotopes ; Corosolic acid ; Cyclic AMP - metabolism ; Cyclic AMP-Dependent Protein Kinases - antagonists &amp; inhibitors ; Cyclic AMP-Dependent Protein Kinases - metabolism ; Endocrinology &amp; Metabolism ; Fructose-2,6-bisphosphate ; Fructosediphosphates - biosynthesis ; Gluconeogenesis ; Gluconeogenesis - drug effects ; Glucose - biosynthesis ; Glucose-6-Phosphatase - metabolism ; Hepatocytes - drug effects ; Hepatocytes - metabolism ; Isoquinolines - pharmacology ; Lactic Acid - metabolism ; Liver ; Liver - drug effects ; Liver - metabolism ; Musa - chemistry ; Plant Extracts - chemistry ; Plant Extracts - pharmacology ; Plant Leaves - chemistry ; Protein Kinase Inhibitors - pharmacology ; Rats ; Rats, Wistar ; Sulfonamides - pharmacology ; Triterpenes - chemistry ; Triterpenes - pharmacology</subject><ispartof>Diabetes research and clinical practice, 2008-04, Vol.80 (1), p.48-55</ispartof><rights>Elsevier Ireland Ltd</rights><rights>2007 Elsevier Ireland Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c484t-f49d0f440de65979afc119db5ac803459f524dc1f61ce96c0c308913dfba5da23</citedby><cites>FETCH-LOGICAL-c484t-f49d0f440de65979afc119db5ac803459f524dc1f61ce96c0c308913dfba5da23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0168822707006055$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18177973$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yamada, Kotaro</creatorcontrib><creatorcontrib>Hosokawa, Masaya</creatorcontrib><creatorcontrib>Fujimoto, Shimpei</creatorcontrib><creatorcontrib>Fujiwara, Hideya</creatorcontrib><creatorcontrib>Fujita, Yoshihito</creatorcontrib><creatorcontrib>Harada, Norio</creatorcontrib><creatorcontrib>Yamada, Chizumi</creatorcontrib><creatorcontrib>Fukushima, Mitsuo</creatorcontrib><creatorcontrib>Ueda, Naoya</creatorcontrib><creatorcontrib>Kaneko, Tetsuo</creatorcontrib><creatorcontrib>Matsuyama, Futoshi</creatorcontrib><creatorcontrib>Yamada, Yuichiro</creatorcontrib><creatorcontrib>Seino, Yutaka</creatorcontrib><creatorcontrib>Inagaki, Nobuya</creatorcontrib><title>Effect of corosolic acid on gluconeogenesis in rat liver</title><title>Diabetes research and clinical practice</title><addtitle>Diabetes Res Clin Pract</addtitle><description>Abstract Corosolic acid (CRA), an active component of Banaba leaves ( Lagerstroemia speciosa L.), decreases blood glucose in diabetic animals and humans. In this study, we investigated the mechanism of action of CRA on gluconeogenesis in rat liver. CRA (20–100 μM) dose-dependently decreased gluconeogenesis in perfused liver and in isolated hepatocytes. Fructose-2,6-bisphosphate (F-2,6-BP), a gluconeogenic intermediate, plays a critical role in hepatic glucose output by regulating gluconeogenesis and glycolysis in the liver. CRA increased the production of F-2,6-BP along with a decrease in intracellular levels of cAMP both in the presence and in the absence of forskolin in isolated hepatocytes. While a cAMP-dependent protein kinase (PKA) inhibitor inhibited hepatic gluconeogenesis, the drug did not intensify the inhibitory effect of CRA on hepatic gluconeogenesis in isolated hepatocytes. These results indicate that CRA inhibits gluconeogenesis by increasing the production of F-2,6-BP by lowering the cAMP level and inhibiting PKA activity in isolated hepatocytes. Furthermore, CRA increased glucokinase activity in isolated hepatocytes without affecting glucose-6-phosphatase activity, suggesting the promotion of glycolysis. These effects on hepatic glucose metabolism may underlie the various anti-diabetic actions of CRA.</description><subject>Animals</subject><subject>cAMP</subject><subject>Carbon Radioisotopes</subject><subject>Corosolic acid</subject><subject>Cyclic AMP - metabolism</subject><subject>Cyclic AMP-Dependent Protein Kinases - antagonists &amp; inhibitors</subject><subject>Cyclic AMP-Dependent Protein Kinases - metabolism</subject><subject>Endocrinology &amp; Metabolism</subject><subject>Fructose-2,6-bisphosphate</subject><subject>Fructosediphosphates - biosynthesis</subject><subject>Gluconeogenesis</subject><subject>Gluconeogenesis - drug effects</subject><subject>Glucose - biosynthesis</subject><subject>Glucose-6-Phosphatase - metabolism</subject><subject>Hepatocytes - drug effects</subject><subject>Hepatocytes - metabolism</subject><subject>Isoquinolines - pharmacology</subject><subject>Lactic Acid - metabolism</subject><subject>Liver</subject><subject>Liver - drug effects</subject><subject>Liver - metabolism</subject><subject>Musa - chemistry</subject><subject>Plant Extracts - chemistry</subject><subject>Plant Extracts - pharmacology</subject><subject>Plant Leaves - chemistry</subject><subject>Protein Kinase Inhibitors - pharmacology</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Sulfonamides - pharmacology</subject><subject>Triterpenes - chemistry</subject><subject>Triterpenes - pharmacology</subject><issn>0168-8227</issn><issn>1872-8227</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1P3DAQhq2qVdnS_oSinLhtOpM4sXMBIQS0ElIP0LPlHY-Rt9kY7A0S_x5vdyUkLj3Zh2e-nleI7wg1AvY_1rULdpU41w2AqhFrQPwgFqhVs9RNoz6KReH0v_-R-JLzGgD6VnafxRFqVGpQ7ULoK--ZtlX0FcUUcxwDVZaCq-JUPYwzxYnjA0-cQ67CVCW7rcbwzOmr-OTtmPnb4T0Wf66v7i9_Lm9_3_y6vLhdktRyu_RycOClBMd9N6jBekIc3KqzpKEsM_iukY7Q90g89ATUgh6wdX5lO2eb9lic7vs-pvg0c96aTcjE42jLYnM2CmQrG9AF7PYglTNyYm8eU9jY9GIQzE6ZWZuDMrNTZhBNUVbqTg4D5tWG3VvVwVEBzvcAlzOfAyeTKfBE7EIq6oyL4b8jzt51oDFMgez4l184r-OcpuLQoMmNAXO3y20XG6iSGHRd-wrRGpPE</recordid><startdate>20080401</startdate><enddate>20080401</enddate><creator>Yamada, Kotaro</creator><creator>Hosokawa, Masaya</creator><creator>Fujimoto, Shimpei</creator><creator>Fujiwara, Hideya</creator><creator>Fujita, Yoshihito</creator><creator>Harada, Norio</creator><creator>Yamada, Chizumi</creator><creator>Fukushima, Mitsuo</creator><creator>Ueda, Naoya</creator><creator>Kaneko, Tetsuo</creator><creator>Matsuyama, Futoshi</creator><creator>Yamada, Yuichiro</creator><creator>Seino, Yutaka</creator><creator>Inagaki, Nobuya</creator><general>Elsevier Ireland Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20080401</creationdate><title>Effect of corosolic acid on gluconeogenesis in rat liver</title><author>Yamada, Kotaro ; Hosokawa, Masaya ; Fujimoto, Shimpei ; Fujiwara, Hideya ; Fujita, Yoshihito ; Harada, Norio ; Yamada, Chizumi ; Fukushima, Mitsuo ; Ueda, Naoya ; Kaneko, Tetsuo ; Matsuyama, Futoshi ; Yamada, Yuichiro ; Seino, Yutaka ; Inagaki, Nobuya</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c484t-f49d0f440de65979afc119db5ac803459f524dc1f61ce96c0c308913dfba5da23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Animals</topic><topic>cAMP</topic><topic>Carbon Radioisotopes</topic><topic>Corosolic acid</topic><topic>Cyclic AMP - metabolism</topic><topic>Cyclic AMP-Dependent Protein Kinases - antagonists &amp; inhibitors</topic><topic>Cyclic AMP-Dependent Protein Kinases - metabolism</topic><topic>Endocrinology &amp; Metabolism</topic><topic>Fructose-2,6-bisphosphate</topic><topic>Fructosediphosphates - biosynthesis</topic><topic>Gluconeogenesis</topic><topic>Gluconeogenesis - drug effects</topic><topic>Glucose - biosynthesis</topic><topic>Glucose-6-Phosphatase - metabolism</topic><topic>Hepatocytes - drug effects</topic><topic>Hepatocytes - metabolism</topic><topic>Isoquinolines - pharmacology</topic><topic>Lactic Acid - metabolism</topic><topic>Liver</topic><topic>Liver - drug effects</topic><topic>Liver - metabolism</topic><topic>Musa - chemistry</topic><topic>Plant Extracts - chemistry</topic><topic>Plant Extracts - pharmacology</topic><topic>Plant Leaves - chemistry</topic><topic>Protein Kinase Inhibitors - pharmacology</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Sulfonamides - pharmacology</topic><topic>Triterpenes - chemistry</topic><topic>Triterpenes - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yamada, Kotaro</creatorcontrib><creatorcontrib>Hosokawa, Masaya</creatorcontrib><creatorcontrib>Fujimoto, Shimpei</creatorcontrib><creatorcontrib>Fujiwara, Hideya</creatorcontrib><creatorcontrib>Fujita, Yoshihito</creatorcontrib><creatorcontrib>Harada, Norio</creatorcontrib><creatorcontrib>Yamada, Chizumi</creatorcontrib><creatorcontrib>Fukushima, Mitsuo</creatorcontrib><creatorcontrib>Ueda, Naoya</creatorcontrib><creatorcontrib>Kaneko, Tetsuo</creatorcontrib><creatorcontrib>Matsuyama, Futoshi</creatorcontrib><creatorcontrib>Yamada, Yuichiro</creatorcontrib><creatorcontrib>Seino, Yutaka</creatorcontrib><creatorcontrib>Inagaki, Nobuya</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Diabetes research and clinical practice</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yamada, Kotaro</au><au>Hosokawa, Masaya</au><au>Fujimoto, Shimpei</au><au>Fujiwara, Hideya</au><au>Fujita, Yoshihito</au><au>Harada, Norio</au><au>Yamada, Chizumi</au><au>Fukushima, Mitsuo</au><au>Ueda, Naoya</au><au>Kaneko, Tetsuo</au><au>Matsuyama, Futoshi</au><au>Yamada, Yuichiro</au><au>Seino, Yutaka</au><au>Inagaki, Nobuya</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of corosolic acid on gluconeogenesis in rat liver</atitle><jtitle>Diabetes research and clinical practice</jtitle><addtitle>Diabetes Res Clin Pract</addtitle><date>2008-04-01</date><risdate>2008</risdate><volume>80</volume><issue>1</issue><spage>48</spage><epage>55</epage><pages>48-55</pages><issn>0168-8227</issn><eissn>1872-8227</eissn><abstract>Abstract Corosolic acid (CRA), an active component of Banaba leaves ( Lagerstroemia speciosa L.), decreases blood glucose in diabetic animals and humans. In this study, we investigated the mechanism of action of CRA on gluconeogenesis in rat liver. CRA (20–100 μM) dose-dependently decreased gluconeogenesis in perfused liver and in isolated hepatocytes. Fructose-2,6-bisphosphate (F-2,6-BP), a gluconeogenic intermediate, plays a critical role in hepatic glucose output by regulating gluconeogenesis and glycolysis in the liver. CRA increased the production of F-2,6-BP along with a decrease in intracellular levels of cAMP both in the presence and in the absence of forskolin in isolated hepatocytes. While a cAMP-dependent protein kinase (PKA) inhibitor inhibited hepatic gluconeogenesis, the drug did not intensify the inhibitory effect of CRA on hepatic gluconeogenesis in isolated hepatocytes. These results indicate that CRA inhibits gluconeogenesis by increasing the production of F-2,6-BP by lowering the cAMP level and inhibiting PKA activity in isolated hepatocytes. Furthermore, CRA increased glucokinase activity in isolated hepatocytes without affecting glucose-6-phosphatase activity, suggesting the promotion of glycolysis. These effects on hepatic glucose metabolism may underlie the various anti-diabetic actions of CRA.</abstract><cop>Ireland</cop><pub>Elsevier Ireland Ltd</pub><pmid>18177973</pmid><doi>10.1016/j.diabres.2007.11.011</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0168-8227
ispartof Diabetes research and clinical practice, 2008-04, Vol.80 (1), p.48-55
issn 0168-8227
1872-8227
language eng
recordid cdi_proquest_miscellaneous_70434208
source MEDLINE; Elsevier ScienceDirect Journals
subjects Animals
cAMP
Carbon Radioisotopes
Corosolic acid
Cyclic AMP - metabolism
Cyclic AMP-Dependent Protein Kinases - antagonists & inhibitors
Cyclic AMP-Dependent Protein Kinases - metabolism
Endocrinology & Metabolism
Fructose-2,6-bisphosphate
Fructosediphosphates - biosynthesis
Gluconeogenesis
Gluconeogenesis - drug effects
Glucose - biosynthesis
Glucose-6-Phosphatase - metabolism
Hepatocytes - drug effects
Hepatocytes - metabolism
Isoquinolines - pharmacology
Lactic Acid - metabolism
Liver
Liver - drug effects
Liver - metabolism
Musa - chemistry
Plant Extracts - chemistry
Plant Extracts - pharmacology
Plant Leaves - chemistry
Protein Kinase Inhibitors - pharmacology
Rats
Rats, Wistar
Sulfonamides - pharmacology
Triterpenes - chemistry
Triterpenes - pharmacology
title Effect of corosolic acid on gluconeogenesis in rat liver
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T08%3A00%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20corosolic%20acid%20on%20gluconeogenesis%20in%20rat%20liver&rft.jtitle=Diabetes%20research%20and%20clinical%20practice&rft.au=Yamada,%20Kotaro&rft.date=2008-04-01&rft.volume=80&rft.issue=1&rft.spage=48&rft.epage=55&rft.pages=48-55&rft.issn=0168-8227&rft.eissn=1872-8227&rft_id=info:doi/10.1016/j.diabres.2007.11.011&rft_dat=%3Cproquest_cross%3E70434208%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70434208&rft_id=info:pmid/18177973&rft_els_id=1_s2_0_S0168822707006055&rfr_iscdi=true